Publications by authors named "C Maari"

Claim this Profile
R
Rapid clinical and transcriptomic response to anifrolumab in refractory anti-TIF1γ-positive juvenile dermatomyositis.
Clément Triaille, Maryam Piram, Benjamin Ellezam, Karine Leveille, Catherine Maari

Ann Rheum Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-Resident Memory and Follicular/Peripheral Helper PD-1 T Cells Infiltrate Lesional Skin in Atopic Dermatitis.
Heena Mehta, Léane Pellerin, Manuel Rubio, Catherine Maari, Étienne S Proulx

Eur J Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1).
Brett King, Maryanne M Senna, Natasha A Mesinkovska, Charles Lynde, Matthew Zirwas, Catherine Maari

J Am Acad Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine Kinase 2 Inhibition With Zasocitinib (TAK-279) in Psoriasis: A Randomized Clinical Trial.
April W Armstrong, Melinda Gooderham, Charles Lynde, Catherine Maari, Seth Forman

JAMA Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.
Mark G Kirchhof, Vimal H Prajapati, Melinda Gooderham, Chih-Ho Hong, Charles W Lynde, Catherine Maari

Dermatol Ther (Heidelb)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis